First Time Loading...
P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 146 100 KRW 3.54% Market Closed
Updated: Jun 1, 2024

PharmaResearch Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Operating Income Peer Comparison

Comparables:
068270
302440
006280
H
145020
A
196170

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Income
₩95.1B
CAGR 3-Years
34%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Income
₩479.3B
CAGR 3-Years
-16%
CAGR 5-Years
10%
CAGR 10-Years
18%
SK Bioscience Co Ltd
KRX:302440
Operating Income
-₩12B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Operating Income
₩33B
CAGR 3-Years
-12%
CAGR 5-Years
2%
CAGR 10-Years
-9%
H
Hugel Inc
KOSDAQ:145020
Operating Income
₩111.7B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
N/A
A
Alteogen Inc
KOSDAQ:196170
Operating Income
-₩9.7B
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Operating Income?
Operating Income
95.1B KRW

Based on the financial report for Mar 31, 2024, PharmaResearch Co Ltd's Operating Income amounts to 95.1B KRW.

What is PharmaResearch Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
64%

Over the last year, the Operating Income growth was 43%. The average annual Operating Income growth rates for PharmaResearch Co Ltd have been 34% over the past three years , 64% over the past five years .